NCT01051440: Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression |
|
|
| Terminated | 4 | 2 | US | Lisdexamfetamine, Vyvanse, Placebo | Steward St. Elizabeth's Medical Center of Boston, Inc., Shire | Bipolar Depression | 06/11 | 06/11 | | |
NCT01148979: Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder. |
|
|
| Completed | 4 | 35 | US | Lisdexamfetamine Dimesylate (Vyvanse), Vyvanse, Placebo, Sugar pill | Mclean Hospital, Shire | Major Depressive Disorder | 09/14 | 10/14 | | |
NCT01863459: Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity |
|
|
| Completed | 4 | 42 | Canada | Lisdexamfetamine Dimesylate, Vyvanse, placebo | Centre for Anxiety, Attention Deficit and Trauma, Ontario, Canada, Shire | Adult Attention Deficit Hyperactivity Disorder (ADHD) With Co-occuring Anxiety and Depressive Disorders | 03/17 | 03/17 | | |
